Exome sequencing offers a higher chance of identifying a genetic diagnosis compared to multigene panels or chromosomal microarray bringing clarity when it matters most.
70% of of genetic disorders begin in childhood.
Yet for many families, the path to a diagnosis is long and costly.
Every Day Without a Genetic Diagnosis Is a Missed Opportunity An earlier diagnosis can do more than provide answers—it can transform care. It helps to:
Leading medical organizations now recognize the power of exome and genome sequencing in early diagnosis.
The American College of Medical Genetics and Genomics (ACMG) recommends exome or genome sequencing as a first-tier test for individuals with developmental delay, intellectual disability, and congenital anomalies.
The National Society of Genetic Counselors (NSGC) recommends exome or genome sequencing for all individuals with unexplained epilepsy—a guideline endorsed by the American Epilepsy Society.
Exome sequencing increases the likelihood of a diagnosis—saving time, guiding treatment, and lowering long-term costs.
higher diagnostic rate than chromosomal microarray
23% of patients diagnosed through exome would have been missed by a standard genetic panel
Join our newsletter to get the latest in genetic health, insights, and breakthroughs delivered straight to your inbox.